Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-22 5:21 pm Purchase | 2023-09-20 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 816,128 12.200% | 153,600 (+23.18%) | Filing History |
| 2023-09-15 5:29 pm Unchanged | 2023-09-13 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-08-08 4:41 pm Unchanged | 2023-08-04 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-07-17 4:34 pm Unchanged | 2023-07-17 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-06-23 10:40 am Purchase | 2023-06-22 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 15,599,863 6.200% | 15,599,863 (New Position) | Filing History |
| 2023-05-30 4:57 pm Purchase | 2023-05-19 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 131,630 (+24.79%) | Filing History |
| 2023-05-02 10:39 am Purchase | 2023-04-25 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 15,599,863 6.200% | 2,347,727 (+17.72%) | Filing History |
| 2023-03-10 11:29 am Purchase | 2023-03-09 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 13,252,136 5.100% | 13,252,136 (New Position) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13G | Mudrick Capital Acquisition Corporation II MUDS | Anson Funds Management LP | 0 0.000% | -2,050,000 (Position Closed) | Filing History |
| 2023-02-14 4:08 pm Unchanged | 2022-12-31 | 13G | LogicMark, Inc. LGMK | Anson Funds Management LP | 1,975 9.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:08 pm Purchase | 2022-12-31 | 13G | View, Inc. VIEW | Anson Funds Management LP | 409,953 9.900% | 409,953 (New Position) | Filing History |
| 2023-02-14 4:07 pm Unchanged | 2022-12-31 | 13G | Appreciate Holdings, Inc. SFRT | Anson Funds Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 530,898 8.000% | 506,550 (+2080.42%) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | Model Performance Acquisition Corp. MPAC | Anson Funds Management LP | 0 0.000% | -456,461 (Position Closed) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | GO Acquisition Corp. GOAC | Anson Funds Management LP | 0 0.000% | -3,268,543 (Position Closed) | Filing History |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Equity Distribution Acquisition Corp. EQD | Anson Funds Management LP | 0 0.000% | -2,969,179 (Position Closed) | Filing History |
| 2022-04-18 4:21 pm Unchanged | 2022-04-18 | 13D | Amarantus BioScience Holdings, Inc. AMBS | Anson Funds Management LP | 14,176,424 4.990% | 0 (Unchanged) | Filing History |
| 2022-04-08 4:05 pm Purchase | 2022-04-01 | 13G | Trilogy International Partners Inc. TRL | Anson Funds Management LP | 9,453,250 10.900% | 1,206,300 (+14.63%) | Filing History |
| 2022-02-11 06:26 am Purchase | 2021-12-31 | 13G | PropTech Investment Corporation II PTIC | Anson Funds Management LP | 1,184,276 5.200% | 1,184,276 (New Position) | Filing History |
| 2022-02-11 06:24 am Purchase | 2021-12-31 | 13G | Nova LifeStyle, Inc. NVFY | Anson Funds Management LP | 74,301 5.300% | 74,301 (New Position) | Filing History |